Bone-marrow microinvolvement in non-small cell lung cancer is not a reliable indicator of tumour recurrence and prognosis

This publication has 14 references indexed in Scilit:

• Immunocytochemical Detection of Disseminated Tumor Cells in the Bone Marrow of Patients With Esophageal Carcinoma
  JNCI Journal of the National Cancer Institute, 1996
• Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases
  The Lancet, 1996
• Micrometastases in bone marrow of patients undergoing “curative” surgery for gastrointestinal cancer
  Gastroenterology, 1995
• Methodological Analysis of Immunocytochemical Screening for Disseminated Epithelial Tumor Cells in Bone Marrow
  Journal of Hematotherapy, 1994
• Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
  The Lancet, 1992
• Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.
  Journal of Clinical Oncology, 1991
• Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.
  Proceedings of the National Academy of Sciences, 1987
• Monoclonal antibody to cytokeratin for use in routine histopathology.
  Journal of Clinical Pathology, 1984
• Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).
  Journal of Histochemistry & Cytochemistry, 1984
• Correlation of specific keratins with different types of epithelial differentiation: Monoclonal antibody studies
  Cell, 1982